StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.39−0.13 (-1.99%)

Close on Nov 13, 2026Market cap $856.72MP/E –Yield –

Immatics statistics

50 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
€768.08M
€768.08M
Enterprise Value
€535.62M
€535.62M

Share statisticsIndustry

Shares Change (YoY)
14.6%
5.61%
Float
122M
79M
Shares Held by Insiders
9.05%
9.05%
Shares Held by Institutions
74.4%
20.8%

Short sellingIndustry

Short Interest
4M
–
Short Interest Change
-2.09%
-2.55%
Days to Cover
3.01
3.54

Stock price statisticsIndustry

Price Change (1 Week)
0.47%
0.08%
Price Change (1 Month)
-10.5%
-2.76%
Price Change (3 Months)
-30.9%
-21.7%
Price Change (6 Months)
-41.2%
-11.3%
Price Change (YTD)
-39.1%
-15.5%
Price Change (1 Year)
-40.1%
-17.6%
Price Change (3 Years)
-34.1%
-8.10%
Price Change (5 Years)
-45.3%
-54.7%
Average Volume (10 Days)
963,144
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
753,409
–
Relative Volume
0.78
0.63
Relative Strength Index (14)
36.0
48.4
Volatility (1 Year)
55.8%
65.2%
Beta (5 Years)
1.21
0.86

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-42.4%
-23.8%

Financial positionIndustry

Current Ratio
7.54
3.49
Quick Ratio
4.18
1.51
Interest Coverage
-4.96
-0.71

GrowthIndustry

EPS Growth (YoY)
-1250.0%
67.4%

EfficiencyIndustry

Employee Count
304
304
WACC
11.1%
9.49%

Income statement (TTM)Industry

Operating Income
-€182.02M
-€54.01M
Pretax Income
-€198.44M
-€47.40M
EBITDA
-€169.62M
-€42.85M
EPS (Diluted)
-1.61 EUR
-0.55 EUR

Balance sheetIndustry

Cash & Short-Term Investments
€232.46M
€199.29M
Net Cash (Debt)
€232.46M
€111.50M
Net Cash Per Share
1.73 EUR
1.53 EUR
Working Capital
€372.24M
€119.55M

Cash flow (TTM)Industry

Operating Cash Flow
-€176.63M
-€42.16M
Capital Expenditures
-€6.56M
-€2.34M
Free Cash Flow
-€183.18M
-€52.90M
FCF Per Share
-1.37 EUR
-0.48 EUR

Dividends and yieldsIndustry

FCF Yield
-23.8%
-13.3%
Buyback Yield
-14.0%
-11.7%
Shareholder Yield
-14.0%
-11.7%

Taxes and interestIndustry

Interest Expense
€36.67M
€55.20M
Income Tax
-€1.99M
€80.00K

Scores and fair valueIndustry

Altman Z-Score
2.42
1.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodIMTXS&P 500DifferenceIMTX per yearS&P 500 per year
1 month-6.4%-3.0%−3.4 pts
3 months-33.4%-2.8%−30.6 pts
Year to date-39.1%+11.5%−50.6 pts
1 year-36.0%+13.5%−49.4 pts
3 years-33.2%+77.7%−110.9 pts-12.6%+21.1%
5 years-45.3%+72.6%−117.9 pts-11.4%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

4M IMTX shares were sold short on Oct 30, 2026, down 2.1% from the previous report. At recent volumes it would take 3.0 days to buy them back. Over the last 20 sessions, 28.2% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,669,476-2.1%1,217,1563.0
Oct 15, 20263,747,677+1.5%1,004,8693.7
Sep 30, 20263,690,633-16.8%888,4334.2
Sep 15, 20264,438,234-8.6%536,5728.3
Aug 31, 20264,853,483-1.4%753,6516.4
Aug 14, 20264,921,838-2.1%331,34114.8
Jul 31, 20265,028,154-0.4%429,17111.7
Jul 15, 20265,047,260-6.7%375,89813.4
Jun 30, 20265,408,927-4.1%406,58413.3
Jun 15, 20265,640,998+17.6%624,8419.0
May 29, 20264,796,236-0.1%503,0779.5
May 15, 20264,801,905-6.9%578,5558.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?